ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Socio-Economic Objective : Diagnostics
Research Topic : Immune dysfunction
Clear All
Filter by Field of Research
Biological And Medical Chemistry (1)
Biophysics (1)
Cellular Immunology (1)
Cellular Interactions (Incl. Adhesion, Matrix, Cell Wall) (1)
Central Nervous System (1)
Clinical Pharmacology And Therapeutics (1)
Colloid And Surface Chemistry (1)
Immunology (1)
Medical Biochemistry: Carbohydrates (1)
Medical Genetics (1)
Neurosciences (1)
Organic Chemical Synthesis (1)
Organic Chemistry (1)
Pharmaceutical Sciences And Pharmacy (1)
Physical Chemistry (Incl. Structural) (1)
Plant Improvement (Selection, Breeding And Genetic Engineering) (1)
Filter by Socio-Economic Objective
Diagnostics (4)
Immune system and allergy (4)
Cancer and related disorders (1)
Treatments (e.g. chemicals, antibiotics) (1)
Wheat (1)
Filter by Funding Provider
Australian Research Council (4)
Filter by Status
Closed (4)
Filter by Scheme
Linkage Projects (2)
Discovery Projects (1)
Linkage Infrastructure, Equipment and Facilities (1)
Filter by Country
Australia (4)
Filter by Australian State/Territory
NSW (2)
QLD (1)
SA (1)
  • Researchers (39)
  • Funded Activities (4)
  • Organisations (23)
  • Funded Activity

    Linkage Projects - Grant ID: LP0668335

    Funder
    Australian Research Council
    Funding Amount
    $411,000.00
    Summary
    Molecular response to interferon beta treatment in multiple sclerosis. Inteferon beta (IFNb) is the frontline drug for treatment of multiple sclerosis. However, in many patients this expensive drug provides no benefit, resulting in unnecessary, uncontrolled disease progression, and in a waste of many millions of dollars each year. A common explanation for this treatment failure is the development of neutralising antibodies (NABs). We will establish the prevalence and effects of NABs in Austra .... Molecular response to interferon beta treatment in multiple sclerosis. Inteferon beta (IFNb) is the frontline drug for treatment of multiple sclerosis. However, in many patients this expensive drug provides no benefit, resulting in unnecessary, uncontrolled disease progression, and in a waste of many millions of dollars each year. A common explanation for this treatment failure is the development of neutralising antibodies (NABs). We will establish the prevalence and effects of NABs in Australian patients, use novel techniques to identify biomarkers for IFNb response, evaluate the diagnostic and therapeutic value of the biomarkers, and develop a new test for NABs. Tailored use of this drug, and possible new therapeutic targets, will result, benefiting the patient and community.
    Read more Read less
    More information
    Funded Activity

    Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0347358

    Funder
    Australian Research Council
    Funding Amount
    $478,000.00
    Summary
    Adelaide high-speed cell sorter and analyser facility. Cell sorting and flow cytometric analysis represent powerful and essential tools in modern cell and molecular biology. The applicants seek to develop a core facility within Adelaide University housing a high-speed Fluorescence Activated Cell Sorter and a high-speed flow cytometric analyser. Such a facility is not currently available to researchers in Adelaide. These high-speed machines will allow studies on rare cells and subcellular compon .... Adelaide high-speed cell sorter and analyser facility. Cell sorting and flow cytometric analysis represent powerful and essential tools in modern cell and molecular biology. The applicants seek to develop a core facility within Adelaide University housing a high-speed Fluorescence Activated Cell Sorter and a high-speed flow cytometric analyser. Such a facility is not currently available to researchers in Adelaide. These high-speed machines will allow studies on rare cells and subcellular components, currently not possible on other machines and meeting the demand for access to this sophisticated equipment is vital for cell and molecular biologists in Adelaide to continue advances in genomics and proteomics.
    Read more Read less
    More information
    Funded Activity

    Linkage Projects - Grant ID: LP0219286

    Funder
    Australian Research Council
    Funding Amount
    $67,635.00
    Summary
    The development of a rapid diagnostic test for heparanase activity. Heparanase is an enzyme that has been implicated in a number of disease states such as cancer, arthritis, multiple sclerosis and other inflammatory diseases. Characterisation of this enzyme has been slow, due in part to the lack of a reliable direct activity assay. Using a multi-disciplinary approach, this project seeks to establish a rapid assay that will provide easy determination of heparanase activity. Furthermore, this a .... The development of a rapid diagnostic test for heparanase activity. Heparanase is an enzyme that has been implicated in a number of disease states such as cancer, arthritis, multiple sclerosis and other inflammatory diseases. Characterisation of this enzyme has been slow, due in part to the lack of a reliable direct activity assay. Using a multi-disciplinary approach, this project seeks to establish a rapid assay that will provide easy determination of heparanase activity. Furthermore, this assay could provide a useful diagnostic tool in a clinical environment that would allow for the rapid assessment of these diseases, their progression and indeed response to therapy.
    Read more Read less
    More information
    Funded Activity

    Discovery Projects - Grant ID: DP0772356

    Funder
    Australian Research Council
    Funding Amount
    $370,000.00
    Summary
    Surface Chemistry meets Cell Biology: Molecular Level Control of Surface Architecture for Cell Adhesion and Migration. Biotechnological applications such as tissue engineering, bone supports, implantable materials, cell assays and biosensors all require detailed knowledge of how cells interact with their environment. The proposed research aims to provide this knowledge by developing unique modified surfaces to investigate white blood cell migration and adhesion. Additional expected outcome will .... Surface Chemistry meets Cell Biology: Molecular Level Control of Surface Architecture for Cell Adhesion and Migration. Biotechnological applications such as tissue engineering, bone supports, implantable materials, cell assays and biosensors all require detailed knowledge of how cells interact with their environment. The proposed research aims to provide this knowledge by developing unique modified surfaces to investigate white blood cell migration and adhesion. Additional expected outcome will contribute to our understanding of the many fundamental cellular processes such as cell growth, differentiation and cell death as well as the molecular basis of diseases such as inflammation, cancer, cardiovascular diseases and wound healing. This research program will establish Australia as a leading force in this new research field.
    Read more Read less
    More information

    Showing 1-4 of 4 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback